Typhoid Fever Vaccine in Thailand Trends and Forecast
The future of the typhoid fever vaccine market in Thailand looks promising with opportunities in the hospital & clinic and specialty center markets. The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 14.5% from 2024 to 2030. The typhoid fever vaccine market in Thailand is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the rise in the prevalence of typhoid and the growing demand for combined vaccines that offer protection against multiple diseases.
• Lucintel forecasts that, within the type category, capsular polysaccharide is expected to witness the highest growth over the forecast period due to its efficiency at preventing infection from bacteria, being safe with limited side effects, and it can be administered orally or by injection, making it easy and convenient to use.
• Within the end use category, hospitals & clinics are expected to witness the highest growth over the forecast period.
Emerging Trends in the Typhoid Fever Vaccine Market in Thailand
The typhoid fever vaccine market in Thailand is undergoing significant developments driven by public health initiatives, technological advancements, and international collaborations. Despite a decline in typhoid incidence over the past decades, the disease remains a public health concern, particularly in certain regions. Emerging trends in vaccine development, policy implementation, and awareness campaigns are shaping the landscape of typhoid prevention in Thailand. Understanding these trends is crucial for stakeholders aiming to enhance public health outcomes and mitigate the risk of future outbreaks.
• Consideration of Typhoid Conjugate Vaccines (TCVs): In March 2018, the World Health Organization recommended TCVs as the preferred typhoid vaccine due to their improved performance and suitability for younger children. Given the significant burden of typhoid in Thailand, with an estimated 84,310 cases in 2019, there is potential for TCV introduction to substantially benefit public health. Implementing TCVs could reduce disease incidence, particularly among children and marginalized populations.
• Decline in Typhoid Incidence Due to Improved Socioeconomic Conditions: Over the past decades, Thailand has experienced a significant decrease in typhoid fever cases, attributed to enhanced socioeconomic factors such as better access to clean water, improved sanitation, and increased female literacy rates. These improvements have collectively reduced the transmission of Salmonella Typhi, leading to lower disease incidence and influencing public health strategies regarding vaccination priorities.
• Focus on Surveillance and Outbreak Preparedness: Despite the decline in cases, Thailand maintains robust surveillance systems to monitor and respond to potential typhoid outbreaks. The emphasis is on early detection, laboratory confirmation, and rapid response to contain any resurgence of the disease. This proactive approach ensures that public health authorities remain prepared to implement targeted vaccination campaigns if necessary.
• Research on Antimicrobial Resistance Trends: Emerging antimicrobial resistance in Salmonella Typhi strains has been observed, with resistance to ciprofloxacin and azithromycin being reported. This trend underscores the importance of continuous monitoring and may influence future vaccine policy decisions, as vaccination could become a more critical tool in managing resistant infections.
• Regional Collaboration for Typhoid Control: Thailand is engaging in regional partnerships to address typhoid fever, recognizing that cross-border movements can influence disease dynamics. Collaborative efforts focus on harmonizing surveillance, sharing data, and coordinating vaccination strategies to effectively manage and prevent typhoid fever across the Southeast Asian region.
In conclusion, the typhoid fever vaccine market in Thailand is being reshaped by the consideration of TCV introduction, improved socioeconomic conditions, robust surveillance systems, research on antimicrobial resistance, and regional collaborations. These trends reflect a comprehensive approach to typhoid prevention, balancing current epidemiological realities with preparedness for potential future challenges.
Recent Developments in the Typhoid Fever Vaccine Market in Thailand
Typhoid fever, caused by Salmonella enterica serovar Typhi, has been a significant public health concern in Thailand, particularly in areas with limited access to clean water and sanitation. Over the years, Thailand has implemented various strategies to control and prevent typhoid fever, including vaccination programs, surveillance enhancements, and international collaborations. These efforts have led to notable developments in the typhoid vaccine market within the country.
• Historical Vaccination Campaigns: In response to a sharp increase in typhoid fever cases in the mid-1970s, Thailand initiated a national immunization program in 1977, targeting schoolchildren aged seven to twelve years. The program involved annual administration of a heat-inactivated typhoid vaccine, leading to a significant decline in typhoid cases in Bangkok. This early intervention demonstrated the effectiveness of mass vaccination in controlling typhoid fever.
• Surveillance and Genomic Studies: To understand the impact of vaccination programs and the evolution of S. Typhi strains, Thailand has conducted whole-genome sequencing analyses of isolates collected before and after the introduction of national immunization efforts. These studies have provided insights into the genetic diversity of S. Typhi and informed public health strategies for typhoid control.
• Policy and Strategic Planning: Thailand has developed comprehensive policies and strategic plans to enhance vaccine production and development within the country. The National Vaccine Security Strategy Policy and Plan aims to ensure vaccine availability, reduce dependence on imports, and promote self-reliance in vaccine production. This initiative aligns with the country commitment to sustainable development and public health security.
• International Collaborations: Thailand has actively participated in international vaccine research initiatives, such as the Diseases of the Most Impoverished (DOMI) program led by the International Vaccine Institute. Through this collaboration, Thailand contributed to studies on typhoid vaccine introduction and disease surveillance, facilitating informed decision-making for vaccine use in developing countries.
• Traveler Vaccination Recommendations: Recognizing the risk of typhoid fever for travelers, especially to endemic areas, Thai healthcare institutions recommend vaccination prior to travel. Vaccines such as the single-dose injectable typhoid vaccine are advised to be administered at least one month before traveling to high-risk regions, underscoring the importance of preventive measures for both residents and visitors.
In summary, Thailand multifaceted approach to combating typhoid fever—including historical vaccination campaigns, enhanced surveillance, strategic policy development, international collaboration, and preventive recommendations for travelers—has significantly influenced the typhoid vaccine market. These efforts have contributed to a substantial reduction in disease incidence and have strengthened the country capacity to manage and prevent typhoid fever.
Strategic Growth Opportunities for Typhoid Fever Vaccine Market in Thailand
The typhoid fever vaccine market in Thailand is witnessing growth due to increased travel, urbanization, and government-led public health initiatives. Thailand, being a regional travel hub, faces risks from imported typhoid cases, especially among tourists, food handlers, and healthcare workers. Strengthening immunization programs, expanding vaccine accessibility, and leveraging technological advancements will drive market expansion. Public-private collaborations, school-based vaccination programs, and digital health tracking will further enhance uptake. These strategic opportunities will ensure sustainable growth and improved protection against typhoid fever in Thailand.
• Pre-Travel Vaccination for Tourists and Outbound Travelers: Thailand is a major tourist destination and a gateway to typhoid-endemic regions. Encouraging pre-travel vaccinations through travel clinics, private hospitals, and airports can boost vaccine adoption. The government can collaborate with airlines and tour operators to integrate typhoid vaccination as a recommended travel health requirement. Public awareness campaigns about typhoid risks in specific destinations can drive vaccine demand. Offering vaccines at international airports and tourism hubs will enhance accessibility. By strengthening travel-related immunization, Thailand can prevent typhoid outbreaks while generating steady demand for vaccines.
• Mandatory Vaccination for Food Industry Workers: Foodborne diseases remain a significant concern in Thailand’s bustling street food and hospitality industry. Implementing mandatory typhoid vaccination for food handlers, particularly in high-risk areas, can reduce contamination risks. Government regulations requiring proof of vaccination for restaurant and street food vendors will drive vaccine uptake. Employers in the food industry can offer subsidized or employer-sponsored vaccination programs. Strengthening health certification for food workers with routine typhoid immunization will ensure long-term demand for vaccines while improving public health safety.
• School-Based Vaccination Programs in High-Risk Areas: Certain regions in Thailand experience a higher prevalence of typhoid, especially in rural and underprivileged communities. Integrating typhoid vaccines into school immunization schedules can protect children and reduce disease transmission. Government-funded school vaccination drives targeting high-risk provinces will improve coverage. Collaborations with NGOs and international health organizations can provide additional support. Digital vaccination records will help track immunization status and booster doses. School-based programs will ensure higher vaccine adoption and contribute to the long-term control of typhoid fever in Thailand.
• Healthcare Worker Immunization Initiatives: Healthcare professionals working in infectious disease management and travel medicine are at higher risk of exposure to typhoid. Implementing mandatory typhoid vaccination policies for healthcare workers in government and private hospitals can enhance protection. Hospitals can integrate typhoid vaccination into routine occupational health checkups. Awareness campaigns emphasizing the risks of typhoid exposure for frontline workers will improve compliance. Providing free or subsidized vaccines to medical staff will encourage higher uptake. Expanding immunization among healthcare professionals will create a consistent demand for typhoid vaccines while reducing transmission risks in healthcare settings.
• Advancements in Typhoid Vaccine Development and Local Production: Thailand’s pharmaceutical sector presents opportunities for investment in next-generation typhoid vaccines. Research and development (R&D) initiatives focused on improved conjugate vaccines with longer immunity can drive market growth. Establishing local manufacturing capabilities will reduce dependency on imports, improve affordability, and ensure steady supply. Strengthening distribution channels through digital health platforms will enhance accessibility, particularly in remote areas. Collaborations with global health organizations can position Thailand as a regional supplier of typhoid vaccines. These advancements will not only drive domestic vaccine adoption but also expand Thailand’s role in the global vaccine market.
The typhoid fever vaccine market in Thailand is set for growth through strategic immunization initiatives, regulatory measures, and technological advancements. Expanding pre-travel vaccination, mandatory immunization for food industry workers, school-based programs, and healthcare worker protection will enhance vaccine uptake. Strengthening local vaccine production and distribution will create sustainable market opportunities. By integrating public health policies with private sector initiatives, Thailand can improve typhoid fever prevention while fostering long-term growth in the vaccine market.
Typhoid Fever Vaccine Market in Thailand Driver and Challenges
The typhoid fever vaccine market in Thailand is influenced by technological, economic, and regulatory factors. Rising international travel, government healthcare initiatives, and advancements in vaccine technology drive market growth. Public health awareness and improved healthcare infrastructure further support immunization efforts. However, regulatory barriers, affordability concerns, and varying disease prevalence create challenges. Understanding these dynamics is essential for healthcare providers, policymakers, and pharmaceutical companies to enhance vaccine accessibility. Addressing both the drivers and challenges will improve disease prevention efforts and ensure that vaccination programs continue to be effective across Thailand.
The factors responsible for driving the typhoid fever vaccine market in Thailand include:
• Growing International Travel and Tourism: Thailand is a global tourism hub, with millions of visitors arriving annually. Thai residents also travel to typhoid-endemic regions, increasing the demand for travel vaccines. Healthcare providers offer vaccination services to tourists and business travelers to prevent disease transmission. Public health authorities emphasize the importance of immunization for travelers, strengthening vaccine uptake. As international travel continues to rise, demand for typhoid fever vaccines is expected to grow. Increasing awareness among travelers and ensuring vaccine availability will further support market expansion and strengthen public health efforts.
• Government Initiatives and Immunization Programs: Thailand has strong public health policies that support immunization programs. The government collaborates with international health organizations to improve vaccine distribution. National vaccination guidelines recommend typhoid vaccines for high-risk groups and travelers. Government-funded healthcare initiatives make vaccines more accessible to the population. Public health campaigns highlight the importance of immunization, encouraging higher vaccine uptake. Continuous investment in healthcare infrastructure and vaccination programs ensures widespread vaccine availability. Strengthening government policies and expanding immunization coverage will further boost the typhoid fever vaccine market in Thailand.
• Advancements in Vaccine Technology: The development of improved vaccine formulations enhances immunization effectiveness. New-generation conjugate vaccines offer longer-lasting immunity, reducing the need for frequent booster doses. Research collaborations between Thai institutions and international pharmaceutical companies drive vaccine innovation. Advancements in manufacturing processes lower production costs and improve vaccine availability. Continued investment in research and development supports the introduction of safer and more efficient vaccines. As vaccine technology advances, public trust in immunization programs is expected to increase. Strengthening research initiatives will further support market growth and disease prevention efforts.
• Increasing Public Awareness of Infectious Diseases: Educational campaigns promote the importance of vaccination in preventing typhoid fever. Healthcare professionals play a key role in educating communities about vaccine benefits. Media coverage and public health organizations emphasize disease prevention through immunization. Public awareness efforts increase vaccine demand and encourage timely immunization. Schools, workplaces, and travel clinics provide vaccination information to at-risk populations. As awareness efforts continue to expand, vaccine uptake is expected to rise. Strengthening education initiatives will further improve immunization rates and enhance public health outcomes across Thailand.
• Expanding Healthcare Infrastructure and Accessibility: Thailand has a well-established healthcare system that supports vaccine distribution. Hospitals, clinics, and pharmacies provide easy access to immunization services. Government and private healthcare providers collaborate to improve vaccine outreach. Digital healthcare solutions enhance vaccine tracking and distribution efficiency. Increased investment in rural healthcare facilities ensures broader vaccine coverage. Improved accessibility encourages higher immunization rates, reducing the risk of disease outbreaks. Strengthening healthcare infrastructure and expanding vaccine distribution networks will further drive market growth and enhance public health protection.
Challenges in the typhoid fever vaccine market in Thailand are:
• Regulatory Barriers and Approval Processes: Thailand has strict regulatory guidelines for vaccine approval to ensure safety and efficacy. Lengthy approval processes can delay the introduction of new vaccines. Pharmaceutical companies must complete extensive clinical trials before receiving regulatory authorization. Complex compliance requirements increase development and distribution costs. Although these measures protect public health, they can slow market expansion. Streamlining regulatory procedures while maintaining safety standards will enhance vaccine accessibility. Balancing stringent regulations with efficient approval processes will support faster vaccine availability and market growth.
• Vaccine Affordability and Economic Constraints: The cost of vaccination can be a barrier for some individuals, particularly in low-income communities. Government programs provide subsidized vaccines, but private healthcare services may involve additional costs. Economic fluctuations impact healthcare spending and vaccine procurement decisions. High prices for new vaccine formulations can limit widespread adoption. Ensuring cost-effective vaccine options will help maintain immunization coverage. Expanding insurance coverage for vaccines and increasing government subsidies can improve affordability. Addressing economic challenges will be essential for sustaining high vaccination rates and preventing typhoid fever cases.
• Variability in Disease Prevalence and Perceived Risk: Typhoid fever prevalence varies across different regions of Thailand. Urban areas with improved sanitation have lower disease incidence, reducing routine vaccine demand. In contrast, rural regions with limited clean water access may experience higher infection rates. Public perception of risk influences vaccine uptake, with lower perceived risk leading to lower immunization rates. Strengthening disease surveillance and targeted immunization programs will help address regional disparities. Promoting vaccination as a preventive measure, even in low-risk areas, will ensure sustained market demand and improved public health protection.
The typhoid fever vaccine market in Thailand benefits from increasing international travel, strong government healthcare initiatives, and advancements in vaccine technology. Expanding healthcare infrastructure and rising public awareness further support market growth. However, regulatory barriers, economic constraints, and varying disease prevalence pose challenges. Addressing these obstacles through streamlined approval processes, cost-effective vaccine solutions, and targeted immunization programs will enhance vaccine accessibility. Strengthening public-private collaborations and government policies will ensure sustained market growth, supporting Thailand’s ongoing efforts to prevent typhoid fever and improve overall public health.
List of Typhoid Fever Vaccine Market in Thailand Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies typhoid fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the typhoid fever vaccine companies profiled in this report include-
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10
Typhoid Fever Vaccine Market in Thailand by Segment
The study includes a forecast for the typhoid fever vaccine market in Thailand by type, route of administration, and end use.
Typhoid Fever Vaccine Market in Thailand by Type [Analysis by Value from 2018 to 2030]:
• Live Attenuated Vaccine
• Capsular Polysaccharide Vaccine
• Conjugate Vaccine
• Others
Typhoid Fever Vaccine Market in Thailand by Route of Administration [Analysis by Value from 2018 to 2030]:
• Oral
• Injection
Typhoid Fever Vaccine Market in Thailand by End Use [Analysis by Value from 2018 to 2030]:
• Hospitals & Clinics
• Specialty Centers
• Others
Features of the Typhoid Fever Vaccine Market in Thailand
Market Size Estimates: Typhoid fever vaccine in Australia market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Typhoid fever vaccine in Australia market size by type, route of administration, end use in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different type, route of administration, end use for the typhoid fever vaccine in Australia.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the typhoid fever vaccine in Australia.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What are the major drivers influencing the growth of the typhoid fever vaccine marketing Thailand?
Answer: The major drivers for this market are the rise in the prevalence of typhoid and the growing demand for combined vaccines that offer protection against multiple diseases.
Q2. What are the major segments of the typhoid fever vaccine market in Thailand?
Answer: The future of the typhoid fever vaccine market in Thailand looks promising with opportunities in the hospital & clinic and specialty center markets.
Q3. Which typhoid fever vaccine market segment in Thailand will be the largest in the future?
Answer: Lucintel forecasts that capsular polysaccharide is expected to witness the highest growth over the forecast period due to its efficiency at preventing infection from bacteria, being safe with limited side effects, and it can be administered orally or by injection, making it easy and convenient to use.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the typhoid fever vaccine market in Thailand by type (live attenuated vaccine, capsular polysaccharide vaccine, conjugate vaccine, and others), route of administration (oral and injection), and end use (hospitals & clinics, specialty centers, and others)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?